Humana HUM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Efficiency | |||||
| Asset turnover | 10.1×+1.2× | 8.9×+0.8× | 8.1×-0.1× | 8.2×-0.1× | |
| Liquidity | |||||
| Current ratio | 7.9×+1.0× | 6.8×+1.1× | 5.7×-0.2× | 5.9×-0.8× | |
| Leverage | |||||
| Debt-to-equity | 2.9×-0.2× | 3.1×+0.2× | 2.8×-0.2× | 3.1×+0.5× | |
| Valuation | |||||
| Market capitalization | $122.85B-21.0% | $155.52B-31.2% | $226.17B-6.0% | $240.61B+9.2% | |
| Price / sales | 1×-0.4× | 1.4×-0.9× | 2.2×-0.4× | 2.7×-0.1× | |
| Price / book | 6.8×-2.5× | 9.3×-4.3× | 13.6×-1.8× | 15.4×+1.0× | |
| Dividend yield | 5.6%+1.0pp | 4.6%+1.6pp | 2.9%+0.4pp | 2.5%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Humana's ratios come from?
- Every ratio is computed from Humana's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
